Press release

E.g., 06/12/2021
E.g., 06/12/2021
International humanitarian and development organization Oxfam urges the senate to put a gender lens on the measures being undertaken by various government agencies to address the specific and disproportionate impacts of the Covid-19 pandemic on women and girls, and marginalized sectors.
International humanitarian and development organization Oxfam urges the senate to put a gender lens on the measures being undertaken by various government agencies to address the specific and disproportionate impacts of the Covid-19 pandemic on women and girls, and marginalized sectors.
The United States government last night moved to support a waiver of intellectual property protections of the Covid-19 vaccine. The People’s Vaccine Alliance has been campaigning to suspend Covid-19 intellectual property protections and has this reaction: This is the decision the world needed: by...
In response to the news that the US has backed a waiver on Intellectual Property for Covid-19 Vaccines, the Peoples Vaccine campaign responded with this reaction: This is the decision the world needed: by backing a waiver of intellectual property protections for COVID-19 vaccines the Biden...
The Peoples Vaccine Alliance (PVA) in Asia is calling on Japan, Singapore and South Korea to take action on the voices of citizens across Asia and the global South by supporting the ‘temporary TRIPS Waiver’ proposal at the WTO’s general council meeting on 30th April, 2021, and ensuring big pharmaceutical companies and rich country governments voluntarily join the WHO-led COVID-19 Technology Access Pool.
The Peoples Vaccine Alliance (PVA) in Asia is calling on Japan, Singapore and South Korea to take action on the voices of citizens across Asia and the global South by supporting the ‘temporary TRIPS Waiver’ proposal at the WTO’s general council meeting on 30th April, 2021, and ensuring big...
The People's Vaccine Campaign: #AskTheCEOs of big pharma
Ahead of shareholder meetings for the giant pharmaceutical corporations, the People’s Vaccine Alliance calculates that Pfizer, Johnson & Johnson and AstraZeneca have paid out $26 billion in dividends and stock buybacks to their shareholders in the past 12 months. This would be enough to pay to...
Subscribe to Press release